1. Home
  2. PDLB vs RGNX Comparison

PDLB vs RGNX Comparison

Compare PDLB & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ponce Financial Group Inc.

PDLB

Ponce Financial Group Inc.

HOLD

Current Price

$17.68

Market Cap

401.0M

Sector

N/A

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$10.15

Market Cap

418.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDLB
RGNX
Founded
1960
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
401.0M
418.1M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
PDLB
RGNX
Price
$17.68
$10.15
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$28.75
AVG Volume (30 Days)
40.4K
495.7K
Earning Date
04-24-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
160.87
18.08
EPS
1.20
N/A
Revenue
N/A
$10,393,000.00
Revenue This Year
N/A
$51.21
Revenue Next Year
N/A
$19.08
P/E Ratio
$14.74
N/A
Revenue Growth
N/A
126.48
52 Week Low
$12.85
$6.89
52 Week High
$18.05
$16.19

Technical Indicators

Market Signals
Indicator
PDLB
RGNX
Relative Strength Index (RSI) 58.19 65.17
Support Level $15.84 $7.76
Resistance Level $18.02 $10.37
Average True Range (ATR) 0.36 0.54
MACD -0.03 0.10
Stochastic Oscillator 69.52 99.53

Price Performance

Historical Comparison
PDLB
RGNX

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: